143 related articles for article (PubMed ID: 9126799)
1. Semiquantitation of intrahepatic MDR3 mRNA levels by reverse transcription/competitive polymerase chain reaction.
Dumoulin FL; Reichel C; Sauerbruch T; Spengler U
J Hepatol; 1997 Apr; 26(4):852-6. PubMed ID: 9126799
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis.
de Vree JM; Jacquemin E; Sturm E; Cresteil D; Bosma PJ; Aten J; Deleuze JF; Desrochers M; Burdelski M; Bernard O; Oude Elferink RP; Hadchouel M
Proc Natl Acad Sci U S A; 1998 Jan; 95(1):282-7. PubMed ID: 9419367
[TBL] [Abstract][Full Text] [Related]
3. MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes.
Trauner M; Fickert P; Wagner M
Semin Liver Dis; 2007 Feb; 27(1):77-98. PubMed ID: 17295178
[TBL] [Abstract][Full Text] [Related]
4. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
Zollner G; Fickert P; Zenz R; Fuchsbichler A; Stumptner C; Kenner L; Ferenci P; Stauber RE; Krejs GJ; Denk H; Zatloukal K; Trauner M
Hepatology; 2001 Mar; 33(3):633-46. PubMed ID: 11230744
[TBL] [Abstract][Full Text] [Related]
5. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood.
Jacquemin E; De Vree JM; Cresteil D; Sokal EM; Sturm E; Dumont M; Scheffer GL; Paul M; Burdelski M; Bosma PJ; Bernard O; Hadchouel M; Elferink RP
Gastroenterology; 2001 May; 120(6):1448-58. PubMed ID: 11313315
[TBL] [Abstract][Full Text] [Related]
6. BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis.
Pauli-Magnus C; Kerb R; Fattinger K; Lang T; Anwald B; Kullak-Ublick GA; Beuers U; Meier PJ
Hepatology; 2004 Mar; 39(3):779-91. PubMed ID: 14999697
[TBL] [Abstract][Full Text] [Related]
7. Progressive familial intrahepatic cholestasis with high gamma-glutamyltranspeptidase levels in Taiwanese infants: role of MDR3 gene defect?
Chen HL; Chang PS; Hsu HC; Lee JH; Ni YH; Hsu HY; Jeng YM; Chang MH
Pediatr Res; 2001 Jul; 50(1):50-5. PubMed ID: 11420418
[TBL] [Abstract][Full Text] [Related]
8. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis.
Deleuze JF; Jacquemin E; Dubuisson C; Cresteil D; Dumont M; Erlinger S; Bernard O; Hadchouel M
Hepatology; 1996 Apr; 23(4):904-8. PubMed ID: 8666348
[TBL] [Abstract][Full Text] [Related]
9. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.
Yamaguchi M; Kita K; Miwa H; Nishii K; Oka K; Ohno T; Shirakawa S; Fukumoto M
Cancer; 1995 Dec; 76(11):2351-6. PubMed ID: 8635042
[TBL] [Abstract][Full Text] [Related]
10. Semiquantitative analysis of intrahepatic cytokine mRNAs in chronic hepatitis C.
Dumoulin FL; Bach A; Leifeld L; El-Bakri M; Fischer HP; Sauerbruch T; Spengler U
J Infect Dis; 1997 Mar; 175(3):681-5. PubMed ID: 9041343
[TBL] [Abstract][Full Text] [Related]
11. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking.
Dixon PH; Weerasekera N; Linton KJ; Donaldson O; Chambers J; Egginton E; Weaver J; Nelson-Piercy C; de Swiet M; Warnes G; Elias E; Higgins CF; Johnston DG; McCarthy MI; Williamson C
Hum Mol Genet; 2000 May; 9(8):1209-17. PubMed ID: 10767346
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C-mediated down-regulation of MDR3 mRNA expression in Chang liver cells.
Wakusawa S; Ikeda R; Shiono Y; Hayashi H
Biochem Pharmacol; 2001 Jun; 61(11):1339-45. PubMed ID: 11331069
[TBL] [Abstract][Full Text] [Related]
13. Progressive familial intrahepatic cholestasis types 1, 2, and 3.
Jansen PL; Müller MM
Gut; 1998 Jun; 42(6):766-7. PubMed ID: 9691911
[No Abstract] [Full Text] [Related]
14. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis.
Lucena JF; Herrero JI; Quiroga J; Sangro B; Garcia-Foncillas J; Zabalegui N; Sola J; Herraiz M; Medina JF; Prieto J
Gastroenterology; 2003 Apr; 124(4):1037-42. PubMed ID: 12671900
[TBL] [Abstract][Full Text] [Related]
15. Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene.
Van Nieuwkerk CM; Elferink RP; Groen AK; Ottenhoff R; Tytgat GN; Dingemans KP; Van Den Bergh Weerman MA; Offerhaus GJ
Gastroenterology; 1996 Jul; 111(1):165-71. PubMed ID: 8698195
[TBL] [Abstract][Full Text] [Related]
16. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis.
Rosmorduc O; Hermelin B; Poupon R
Gastroenterology; 2001 May; 120(6):1459-67. PubMed ID: 11313316
[TBL] [Abstract][Full Text] [Related]
17. Liver diseases related to MDR3 (ABCB4) gene deficiency.
Gonzales E; Davit-Spraul A; Baussan C; Buffet C; Maurice M; Jacquemin E
Front Biosci (Landmark Ed); 2009 Jan; 14(11):4242-56. PubMed ID: 19273348
[TBL] [Abstract][Full Text] [Related]
18. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor α activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion.
Ghonem NS; Ananthanarayanan M; Soroka CJ; Boyer JL
Hepatology; 2014 Mar; 59(3):1030-42. PubMed ID: 24122873
[TBL] [Abstract][Full Text] [Related]
20. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
Jansen PL; Strautnieks SS; Jacquemin E; Hadchouel M; Sokal EM; Hooiveld GJ; Koning JH; De Jager-Krikken A; Kuipers F; Stellaard F; Bijleveld CM; Gouw A; Van Goor H; Thompson RJ; Müller M
Gastroenterology; 1999 Dec; 117(6):1370-9. PubMed ID: 10579978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
